<DOC>
	<DOCNO>NCT02521207</DOCNO>
	<brief_summary>The study compare study drug already market formulation prescription strength ibuprofen ( Brufen速 reference product ) look drug take body also perform specialist procedure call endoscopy ( specifically , gastroscopy ) . The safety tolerability study drug also assess . The study consist 2 part involve 54 healthy male female subject . Subjects randomly assign receive either study drug reference product . Part 1 cross study 10 subject receive single dose 800 mg study drug OXP001 Brufen速 Day 1 , single dose 800 mg study drug OXP001 Brufen速 Day 4 . Part 1 assess bioavailability involve interim decision progression Part 2 . In Part 2 , 44 subject receive dose 800 mg OXP001 Brufen速 three time daily 7 day order ass pharmacokinetics stomach irritation use endoscopy .</brief_summary>
	<brief_title>Pilot Study OXP001 ( 2 ) Brufen Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Healthy male female subject Healthy , normal upper GI tract indicate ulcer erosion baseline , assessed gastroenterologist conduct endoscopy ( ie Lanza score 0 stomach duodenum ) ( Part 2 ) H. pylorus negative Clinically significant abnormal laboratory parameter Any clinically significant disease condition affect haematopoietic , cardiovascular , renal , hepatic , endocrine , pulmonary , central nervous , immunological , dermatological , GI body system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>